☰

Jeffrey L. Evelhoch - Publications

Affiliations: 
Wayne State University, Detroit, MI, United States 
Area:
Radiology, Radiation Physics, Medical Biophysics
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, et al. Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. Journal of Magnetic Resonance Imaging : Jmri. PMID 30680836 DOI: 10.1002/Jmri.26598  0.343
2019 Keenan KE, Biller JR, Boss MA, Peskin AP, Stupic KF, Russek SE, Delfino J, Does M, Evelhoch JL, Griswold M, Gunter J, Hinks RS, Hoffman S, Kim G, Lattanzi R, et al. Progress Towards Standards for Quantitative MRI (qMRI) and Outstanding Needs Journal of Magnetic Resonance Imaging. 49. DOI: 10.1002/Https://Doi.Org/10.1002/Jmri.26598  0.318
2018 Evelhoch JL. In vivo MR in the drug pipeline. Journal of Magnetic Resonance (San Diego, Calif. : 1997). PMID 29716831 DOI: 10.1016/J.Jmr.2018.04.012  0.312
2017 Keenan KE, Ainslie M, Barker AJ, Boss MA, Cecil KM, Charles C, Chenevert TL, Clarke L, Evelhoch JL, Finn P, Gembris D, Gunter JL, Hill DLG, Jack CR, Jackson EF, et al. Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom. Magnetic Resonance in Medicine. PMID 29083101 DOI: 10.1002/Mrm.26982  0.372
2016 Campbell BR, Gonzalez Trotter D, Hines CD, Li W, Patel M, Zhang W, Evelhoch JL. In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs. Ilar Journal. 57: 212-220. PMID 28053073 DOI: 10.1093/Ilar/Ilw019  0.319
2014 Seah S, Asad AB, Baumgartner R, Feng D, Williams DS, Manigbas E, Beaver JD, Reese T, Henry B, Evelhoch JL, Chin CL. Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study. Plos One. 9: e110432. PMID 25337714 DOI: 10.1371/Journal.Pone.0110432  0.344
2013 Becerra L, Upadhyay J, Chang PC, Bishop J, Anderson J, Baumgartner R, Schwarz AJ, Coimbra A, Wallin D, Nutile L, George E, Maier G, Sunkaraneni S, Iyengar S, Evelhoch JL, et al. Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects. The Journal of Pharmacology and Experimental Therapeutics. 345: 41-51. PMID 23370795 DOI: 10.1124/Jpet.112.201145  0.335
2013 Schmidt E, Blackman S, Iannone R, Senderak E, Railkar R, Evelhoch J, Mozley P, Perez E, McDonough M, Rimawi M, Tolaney S, Kim S, Chung H. Abstract P4-01-11: Limits of [18F]-FLT PET as a clinical biomarker of proliferation in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-01-11  0.377
2011 Rossin R, Kohno T, Hagooly A, Sharp T, Gliniak B, Arroll T, Chen Q, Hewig A, Kaplan-Lefko P, Friberg G, Radinsky R, Evelhoch JL, Welch MJ, Hwang DR. Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 942-9. PMID 21571804 DOI: 10.2967/Jnumed.110.086157  0.335
2009 Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, Rosen LS. Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3557-65. PMID 19546406 DOI: 10.1200/Jco.2008.19.6683  0.332
2006 Arias-Mendoza F, Payne GS, Zakian KL, Schwarz AJ, Stubbs M, Stoyanova R, Ballon D, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, et al. In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. Nmr in Biomedicine. 19: 504-12. PMID 16763965 DOI: 10.1002/Nbm.1057  0.345
2005 Evelhoch J, Garwood M, Vigneron D, Knopp M, Sullivan D, Menkens A, Clarke L, Liu G. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. Cancer Research. 65: 7041-4. PMID 16103049 DOI: 10.1158/0008-5472.Can-05-0674  0.385
2005 Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, et al. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5464-73. PMID 16027440 DOI: 10.1200/Jco.2005.04.143  0.362
2005 Spees WM, Evelhoch JL, Thompson PA, Sloop DJ, Ackerman JJ. Defining the pHi-hyperthermia sensitivity relationship for the RIF-1 tumor in vivo: a 31P MR spectroscopy study. Radiation Research. 164: 86-99. PMID 15966768 DOI: 10.1667/Rr3390  0.377
2005 Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. British Journal of Cancer. 92: 1599-610. PMID 15870830 DOI: 10.1038/Sj.Bjc.6602550  0.35
2004 Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. Nmr in Biomedicine. 17: 382-91. PMID 15386624 DOI: 10.1002/Nbm.915  0.335
2004 Bezabeh T, Evelhoch JL, Sloop DJ, Ackerman JJ. Methodology for applied 4 MHz RF hyperthermia concomitant with 31P NMR spectroscopic monitoring of murine tumours. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 20: 637-45. PMID 15370819 DOI: 10.1080/0265673042000196478  0.337
2004 Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3650-7. PMID 15173071 DOI: 10.1158/1078-0432.Ccr-03-0417  0.394
2003 Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson G, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin G, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. The British Journal of Radiology. 76: S87-91. PMID 15456718 DOI: 10.1259/Bjr/15917261  0.322
2000 Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (New York, N.Y.). 2: 152-65. PMID 10933074 DOI: 10.1038/Sj.Neo.7900078  0.399
2000 Gillies RJ, Bhujwalla ZM, Evelhoch J, Garwood M, Neeman M, Robinson SP, Sotak CH, Van Der Sanden B. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (New York, N.Y.). 2: 139-51. PMID 10933073 DOI: 10.1038/Sj.Neo.7900076  0.4
2000 He Z, Evelhoch JL, Mohammad RM, Adsay NV, Pettit GR, Vaitkevicius VK, Sarkar FH. Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer Pancreas. 21: 69-76. PMID 10881935 DOI: 10.1097/00006676-200007000-00054  0.392
1999 Taylor JS, Tofts PS, Port R, Evelhoch JL, Knopp M, Reddick WE, Runge VM, Mayr N. MR imaging of tumor microcirculation: promise for the new millennium. Journal of Magnetic Resonance Imaging : Jmri. 10: 903-7. PMID 10581502 DOI: 10.1002/(Sici)1522-2586(199912)10:6<903::Aid-Jmri1>3.0.Co;2-A  0.401
1999 Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology Journal of Magnetic Resonance Imaging. 10: 254-259. PMID 10508284 DOI: 10.1002/(Sici)1522-2586(199909)10:3<254::Aid-Jmri5>3.0.Co;2-9  0.348
1999 Simpson NE, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors Magnetic Resonance in Medicine. 42: 240-247. PMID 10440948 DOI: 10.1002/(Sici)1522-2594(199908)42:2<240::Aid-Mrm5>3.0.Co;2-8  0.369
1999 Simpson NE, He Z, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods Magnetic Resonance in Medicine. 42: 42-52. PMID 10398949 DOI: 10.1002/(Sici)1522-2594(199907)42:1<42::Aid-Mrm8>3.0.Co;2-Z  0.315
1997 Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension. 30: 654-9. PMID 9322999 DOI: 10.1161/01.Hyp.30.3.654  0.301
1997 Soulen RL, Romero JA, Chuba PJ, Evelhoch JL, Simpson RE, Forman JD. Musculoskeletal complications of neutron therapy for prostate cancer. Radiation Oncology Investigations. 5: 81-91. PMID 9303061 DOI: 10.1002/(Sici)1520-6823(1997)5:2<81::Aid-Roi6>3.0.Co;2-F  0.321
1996 Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. Journal of Neurosurgery. 84: 449-58. PMID 8609557 DOI: 10.3171/Jns.1996.84.3.0449  0.361
1996 Zhao M, Pipe JG, Bonnett J, Evelhoch JL. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo British Journal of Cancer. 73: 61-64. PMID 8554985 DOI: 10.1038/Bjc.1996.11  0.319
1995 Zhao M, Fortan LG, Evelhoch JL. The effects of isoflurane and halothane on blood flow and 31P NMR spectra in murine RIF‐1 tumors Magnetic Resonance in Medicine. 33: 610-618. PMID 7596264 DOI: 10.1002/Mrm.1910330505  0.332
1994 Leach MO, Arnold D, Brown TR, Charles HC, de Certaines JD, Evelhoch JL, Margulis AR, Negendank WG, Nelson SJ, Podo F. International Workshop on Standardization in Clinical Magnetic Resonance Spectroscopy Measurements: proceedings and recommendations. Academic Radiology. 1: 171-86. PMID 9419483 DOI: 10.1016/S1076-6332(05)80838-4  0.331
1992 Evelhoch JL, McDouall JBL, Mattiello J, Simpson NE. Measurement of relative regional tumor blood flow in mice by deuterium NMR imaging Magnetic Resonance in Medicine. 24: 42-52. PMID 1532621 DOI: 10.1002/Mrm.1910240105  0.355
1992 Evelhoch JL. Measurement of tumor blood flow by deuterium NMR and the effects of modifiers Nmr in Biomedicine. 5: 290-295. PMID 1449970 DOI: 10.1002/Nbm.1940050516  0.334
1991 Larcombe-Mcdouall JB, Mattiello J, McCoy CL, Simpson NE, Seyedsadr M, Evelhoch JL. Size dependence of regional blood flow in murine tumours using deuterium magnetic resonance imaging International Journal of Radiation Biology. 60: 109-113. PMID 1677956 DOI: 10.1080/09553009114551651  0.321
1991 Mattiello J, Evelhoch JL. Relative volume-average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopy Magnetic Resonance in Medicine. 18: 320-334. PMID 1646371 DOI: 10.1002/Mrm.1910180207  0.356
1990 Mattiello J, Evelhoch JL, Brown E, Schaap AP, Hetzel FW. Effect of photodynamic therapy on RIF‐1 tumor metabolism and blood flow examined by 31P and 2H NMR spectroscopy Nmr in Biomedicine. 3: 64-70. PMID 2390455 DOI: 10.1002/Nbm.1940030204  0.324
1989 Evelhoch JL. In vivo19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism Investigational New Drugs. 7: 5-12. PMID 2661482 DOI: 10.1007/Bf00178187  0.379
1987 Evelhoch JL, Keller NA, Corbett TH. An examination of the specificity of in vivo 31P MRS adriamycin response markers Annals of the New York Academy of Sciences. 508: 426-428. DOI: 10.1111/J.1749-6632.1987.Tb32926.X  0.304
1986 Evelhoch JL, Sapareto SA, Nussbaum GH, Ackerman JJ. Correlations between 31P NMR spectroscopy and 15O perfusion measurements in the RIF-1 murine tumor in vivo. Radiation Research. 106: 122-31. PMID 3961103 DOI: 10.2307/3576567  0.35
Show low-probability matches.